Showing posts with label red cell. Show all posts
Showing posts with label red cell. Show all posts

Friday, 4 February 2011

MALARIA: Red blood cell defects and malaria

Thomas N. Williamsa, Kemri/Wellcome Trust Collaborative Programme, P.O. Box 230, Kilifi, Kenya
Nuffield Department of Medicine, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford OX3 7LJ, UK
accepted 22 May 2006.
Abstract
Malaria is a major cause of childhood death throughout much of the tropical world. As a result, it has exerted a powerful force for the evolutionary selection of genes that confer a survival advantage. Identifying which genes are involved, and how they affect malaria risk, is a potentially useful way of exploring the host–parasite relationship. To date, some of the best-described malaria-protective polymorphisms relate to genes that affect the structure or function of red blood cells (RBC). Recent years have seen significant advances in our understanding of the importance of some of these genes, including glycophorin C (GYPC); complement receptor 1 (CR1); band 3 (SLC4A1); pyruvate kinase (Pklr); and the genes for α-(HBA) and β-globin (HBB). The challenge for the future must be to convert these advances into fresh approaches to the prevention and treatment of malaria.
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T29-4K4WFFS-1&_user=10&_coverDate=10%2F31%2F2006&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0d758dc0cc2334fa9532c15930728a9e&searchtype=a

Saturday, 22 January 2011

MALARIA: Malaria Parasite Caught Red-Handed Invading Blood Cells

ScienceDaily (Jan. 19, 2011) — Australian scientists using new image and cell technologies have for the first time caught malaria parasites in the act of invading red blood cells. The researchers, from the Walter and Eliza Hall Institute in Melbourne, Australia, and the University of Technology, Sydney (UTS), achieved this long-held aim using a combination of electron, light and super resolution microscopy, a technology platform new to Australia.

This image is a composite showing the behavior of different parts of the malaria parasite as it invades a red blood cell, at nanometer scales. The three components of the malaria parasite are labeled with fluorescent proteins (blue = parasite nucleus, red = secretory organelle, green = tight junction). The red blood cell is superimposed on the image for context. Image 1 (Attachment): The parasite is about to invade the red blood cell (unseen to the right of the picture). The tight junction (green) is like a window that the parasite brings with it and inserts into the red blood cell to gain entry. Image 2 (Invasion): This image is mid-invasion, the first time this step has even been visualized. The parasite "opens" the window it has inserted into the cell, and walks through. The secretory organelle (red) secretes its contents through the tight junction (green) and creates a vacuole which the parasite lives within in the red blood cell. In this image we see the parasite nucleus (blue) moving through the ‘window’ into the cell. Image 3 (Sealing): The parasite has completed invasion and is within a vacuole inside the host red blood cell. The window has been closed again, and will break down at a later stage. The parasite is now enclosed within its vacuole (red), the nucleus (blue) showing the parasite safely inside. (Credit: David Riglar and Jacob Baum (Walter and Eliza Hall Institute) with support from Cynthia Whitchurch and Lynne Turnbull (University of Technology, Sydney).)

The detailed look at what occurs as the parasite burrows through the walls of red blood cells provides new insights into the molecular and cellular events that drive cell invasion and may pave the way for developing new treatments for malaria. Institute researchers Dr Jake Baum, Mr David Riglar, Dr Dave Richard and colleagues from the institute's Infection and Immunity division led the research with colleagues from the i3 institute at UTS.
Dr Baum said the real breakthrough for the research team had been the ability to capture high-resolution images of the parasite at each and every stage of invasion, and to do so reliably and repeatedly. Their findings are published in today's issue of the journal Cell Host & Microbe.
"It is the first time we've been able to actually visualise this process in all its molecular glory, combining new advances developed at the institute for isolating viable parasites with innovative imaging technologies," Dr Baum said.

"Super resolution microscopy has opened up a new realm of understanding into how malaria parasites actually invade the human red blood cell. Whilst we have observed this miniature parasite drive its way into the cell before, the beauty of the new imaging technology is that it provides a quantum leap in the amount of detail we can see, revealing key molecular and cellular events required for each stage of the invasion process."
The imaging technology, called OMX 3D SIM super resolution microscopy, is a powerful new 3D tool that captures cellular processes unfolding at nanometer scales. The team worked closely with Associate Professor Cynthia Whitchurch and Dr Lynne Turnbull from the i3 institute at UTS to capture these images.
"This is just the beginning of an exciting new era of discoveries enabled by this technology that will lead to a better understanding of how microbes such as malaria, bacteria and viruses cause infectious disease," Associate Professor Whitchurch said.
Dr Baum said the methodology would be integral to the development of new malaria drugs and vaccines. "If, for example, you wanted to test a particular drug or vaccine, or investigate how a particular human antibody works to protect you from malaria, this imaging approach now gives us a window to see the actual effects that each reagent or antibody has on the precise steps of invasion," he said.
Malaria is caused by the Plasmodium parasite, which is transmitted by the bite of infected mosquitoes. Each year more than 400 million people contract malaria, and as many as a million, mostly children, die.
"Historically it has been very difficult to both isolate live and viable parasites for infection of red blood cells and to employ imaging technologies sensitive enough to capture snapshots of the invasion process with these parasites, which are only one micron (one millionth of a metre) in diameter," Dr Baum said.
He said one of the most interesting discoveries the imaging approach revealed was that once the parasite has attached to the red blood cell and formed a tight bond with the cell, a master switch for invasion is initiated and invasion will continue unabated without any further checkpoints.
"The parasite actually inserts its own window into the cell, which it then opens and uses to walk into the cell, which is quite extraordinary," Dr Baum said. "Visually tracking the invasion of Plasmodium falciparum into a red blood cell is something I've been aiming at ever since I began at the Walter and Eliza Hall Institute in 2003; it's really thrilling to have reached that goal. This technology enables us to look at individual proteins that we always knew were involved in invasion, but we never knew what they did or where they were, and that, we believe, is a real leap for malaria researchers worldwide."
This work was supported by the National Health and Medical Research Council, The University of Melbourne, Canadian Institutes of Health, the University of Technology, Sydney, and the Australian Research Council.
http://www.sciencedaily.com/releases/2011/01/110119125308.htm

Sunday, 6 June 2010

MALARIA: Drug developed to prevent parasite entry into red cell

CANBERRA, June 3 (Xinhua) -- Australian scientists on Thursday said they have found a unique way to block a malaria infection, opening up a new front in the war on the mosquito-borne parasite which infects 400 million people every year, Australian Associated Press reported on Thursday.
Researchers at the Melbourne-based Walter and Eliza Hall Institute for Medical Research have identified an alternative method to that used by conventional treatments, which kills off the parasite once it has gained access to a person's red blood cells.
The institute's Dr James Beeson said the new method had proven capable of stopping the parasite from entering the cells altogether, robbing it of the safe haven it needed to multiply while hiding from the body's defenses.
"All of the currently licensed anti-malarial drugs that are used in humans act by inhibiting or slowing down the development of the parasite once it is inside the red blood cell," Beeson said.
"This (alternative) approach is to block the parasite from getting inside the red blood cell in the first place ... it would be ideal to use this approach in combination with an existing anti- malarial so it would be a two-pronged attack.
"One would try to stop the parasite from getting in and the other would be trying to stop the development of any parasite within the red blood cells."
The scientists found the blood-thinning drug heparin, which is used to treat blood clots, was effective at stopping the malaria parasite, most commonly Plasmodium falciparum, from attaching and burrowing into red blood cells.
They then developed similar molecules that boosted this effect against the parasite but had no blood-thinning effect.
Beeson said trials to ensure its safety, reformulated and "two- pronged" anti-malarial treatments could be introduced to the world in five to 10 years.
It would boost the protection for travelers in malaria-prone developing nations and provide a more effective treatment for malaria once infection took hold, resulting in less sickness and fewer deaths.
About one million people, mostly children, die as a result of malaria every year.

http://news.xinhuanet.com/english2010/health/2010-06/03/c_13331265.htm